Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Osteoporosis Reports
Erschienen in: Current Osteoporosis Reports 4/2011

01.12.2011 | Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Rickets

verfasst von: M. Zulf Mughal

Erschienen in: Current Osteoporosis Reports | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Rickets is disorder of a growing child arising from disorders that result in impaired apoptosis of hypertrophic cells and mineralization of the growth plate. Rickets due to nutritional causes remains an important global problem. The factors responsible for resurgence of rickets among dark-skinned infants living in developed countries include the following: residence in northern or southern latitudes, voluntary avoidance of exposure to solar ultraviolet B radiation, maternal vitamin D deficiency during pregnancy, and prolonged breastfeeding without provision of vitamin D supplements. Fibroblast growth factor 23 (FGF23), secreted by osteocytes, is an important regulator of serum phosphate and 1,25(OH)2D3 levels. Hypophosphatemic rickets resulting from increased synthesis or under-catabolism of FGF23 is reviewed.
Literatur
1.
2.
Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci USA. 2005;102:9637–42.PubMedCrossRef
3.
•• Tiosano D & Hochberg Z Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab. 2009;27(4):392–401. This paper proposes a new classification for the differential diagnosis of rickets, which is based on the mechanisms leading to hypophosphatemia-high PTH activity, high FGF23 activity, or renal phosphaturia.
4.
Casella SJ, Reiner BJ, Chen TC, Holick MF. A possible defect in 25-hydroxylation as a cause of rickets. J Pediatr. 1994;124:929–32.PubMedCrossRef
5.
Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA. 2004;101:7711–5.PubMedCrossRef
6.
Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr. 2006;26:1–16.PubMedCrossRef
7.
Allgrove J. Is nutritional rickets returning? Archives of Disease in Childhood. 2004;89(8):699–701.PubMedCrossRef
8.
Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. European Journal of Endocrinology. 2009;160(3):491–7.PubMedCrossRef
9.
Ward LM, Gaboury I, Ladhani M, Zlotkin S. Vitamin D-deficiency rickets among children in Canada. Canadian Medical Association Journal. 2007;177(2):161–6.PubMedCrossRef
10.
McGillivray G, Skull SA, Davie G, et al. High prevalence of asymptomatic vitamin D and iron deficiency in East African immigrant children and adolescents living in a temperate climate. Archives of Disease in Childhood. 2007;92(12):1088–93.PubMedCrossRef
11.
Agarwal KS, Mughal MZ, Upadhyay P, Berry J, Mawer EB, J.M. P. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Chld. 2002; 87: 111–113.
12.
Das G, Crocombe S, McGrath M, Berry JL, Mughal MZ. Hypovitaminosis D among healthy adolescent girls attending an inner city school. Archives of Disease in Childhood. 2006;91(7):569–72.PubMedCrossRef
13.
van der Meer IM, Karamali NS, Boeke AJ. High prevalence of vitamin D deficiency in pregnant non-Western women in the Hague, Netherlands. Am J Clin Nutr. 2006;84(2):350–3.
14.
Dijkstra SH, van Beek A, Janssen JW, de Vleeschouwer LH, Huysman WA, van den Akker EL. High prevalence of vitamin D deficiency in newborns of high-risk mothers. Arch Dis Chld Fetal Neonatal Ed. 2007
15.
Clemens TL, Adams JS, Henderson SL. Holick MF Increased skin pigmentation reduces the capacity of skin to synthesize vitamin D3. Lancet. 1982;1:74–6.PubMedCrossRef
16.
Crowe FL, Steur M, Allen NE, Appleby PN, Travis RC, Key TJ. Plasma concentrations of 25-hydroxyvitamin D in meat eaters, fish eaters, vegetarians and vegans: results from the EPIC-Oxford study. Public Health Nutr. 2011;14(2):340–6.PubMedCrossRef
17.
Clements M R, Johnson L, Fraser D R. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987. 32562–65.65.
18.
A Khadilkar, G Das, M Sayyad, N Sanwalka, D Bhandari, V Khadilkar, M Z Mughal. Letter. Low Calcium intake & Hypovitaminosis D in Adolescent Girls. Archives of Disease in Childhood. 2007;92 (11):1045.
19.
Mughal MZ, Salama H, Greenaway T, Laing I, Mawer EB. Florid rickets associated with prolonged breast feeding without vitamin D supplementation. BMJ. 1999;318:39–40.PubMedCrossRef
20.
Awumey EMK, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the South United States: a Clinical Research Center Study. J Clin Endocrinol Metab. 1998;83:169–73.PubMedCrossRef
21.
Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180–8.PubMedCrossRef
22.
DeLucia MC, Mitnick ME, Carpenter TO. Nutritional rickets with normal circulating 25-hydroxyvitamin D: a call for reexamining the role of dietary calcium intake in North American infants. J Clin Endocrinol Metab. 2003;88(8):3539–45.PubMedCrossRef
23.
Gordon CM, Williams AL, Feldman HA, May J, Sinclair L, Vasquez A, et al. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab. 2008;93:2716–21.PubMedCrossRef
24.
Shah BR, Finberg L. Single-dose therapy for nutritional vitamin D-deficiency rickets: a preferred method. J Pediatr. 1994;125:487–90.PubMedCrossRef
25.
Dunnigan M G, Glekin B M, Henderson J B. et al Prevention of rickets in Asian children: assessment of the Glasgow campaign. BMJ 1985. 291(6490)239–242.242.
26.
Hatun S, Ozkan B, Bereket A. Vitamin D deficiency and prevention: Turkish experience. Acta Paediatr. 2011;100(9):1195–9.PubMedCrossRef
27.
Malloy PJ, Feldman D. Genetic disorders and defects in vitamin D action. Endocrinol Metab Clin North Am. 2010;39(2):333–46.PubMedCrossRef
28.
•• Bergwitz C & Juppner H. 2010 Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annual Review of Medicine 61 91–104. Most insights gained into the regulation of phosphate homeostasis by these factors (PTH, vitamin D, and FGF23) are derived from human genetic disorders and genetically engineered mice, which are reviewed in this paper.
29.
Gattineni J, Bates C, Twombley K, et al. FGF-23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009;297:F282–91.PubMedCrossRef
30.
31.
Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113:561–8.PubMed
32.
Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alphahydroxylase expression in vitro. Am J Physiol Renal Physiol. 2007;293:F1577–83.PubMedCrossRef
33.
Hyp_Consortium. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11:130–6.CrossRef
34.
Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM. Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int. 2009;85:235–46.PubMedCrossRef
35.
•• Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res. 2011 Jul;26(7):1381–8. This paper briefly reviews the clinical and pathophysiologic features XLH and offers a guide in response to the conference recommendation.
36.
Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008;3:658–64.PubMedCrossRef
37.
Yavropoulou MP, Kotsa K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, et al. Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones (Athens). 2010;9(3):274–8.
38.
Yang HM, Mao M, Yang F, Wan C. Recombinant growth hormone therapy for X-linked hypophosphatemia in children. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004447. doi:10.​1002/​14651858.​CD004447.
39.
Petje G, Meizer R, Radler C, Aigner N, Grill F. Deformity correction in children with hereditary hypophosphatemic rickets. Clin Orthop Relat Res. 2008;466(12):3078–85.PubMedCrossRef
40.
Souza MA, Jr Soares LA, Santos MA, Vaisbich MH. Dental abnormalities and oral health in patients with Hypophosphatemic rickets. Clinics (Sao Paulo). 2010;65(10):1023–6.
41.
Imel EA, DiMeglio LA, Hui SL, et al. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab. 2010;95:1846–50.PubMedCrossRef
42.
Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, et al. Therapeutic effects of Anti-FGF-23 antibodies in hypophosphatemic rickets/osteomalacia. J Bone Miner Res. 2009;24:1879–88.PubMedCrossRef
43.
Liu ES, Carpenter TO, Gundberg CM, Simpson CA, Insogna KL. Calcitonin Administration in X-Linked Hypophosphatemia. N Engl J Med. 2011;364(17):1678–80.PubMedCrossRef
44.
ADHR consortium Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23. Nat Genet. 2000;26:345–348.
45.
Bai XY, Miao D, Goltzman D, Karaplis AC. The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem. 2003;278:9843–9.PubMedCrossRef
46.
Imel EA, Hui SL, Econs MJ. FGF-23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res. 2007;22(4):520–6.PubMedCrossRef
47.
Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet. 2006;38:1310–5.PubMedCrossRef
48.
Lorenz-Depiereux B, Bastepe M, Benet-Pages A, Amyere M, Wagenstaller J, Muller-Barth U, et al. DMP1 mutations in autosomal recessive hypophosphatemiaimplicate a bone matrix protein in the regulation of phosphate homeostasis. Nature Genet. 2006;38:1248–50.PubMedCrossRef
49.
Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, et al. Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet. 2003;34:379–81.PubMedCrossRef
50.
Rutsch F, Böyer P, Nitschke Y, et al. Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet. 2008;1:133–40.PubMedCrossRef
51.
Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet. 2010;86:267–72.PubMedCrossRef
52.
Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet. 2010;86:273–8.PubMedCrossRef
53.
Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683–92.PubMed
54.
Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18:R53–77.PubMedCrossRef
55.
Jung GH, Kim JD, Cho Y, et al. A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets. J Pediatr Orthop B. 2010;19(1):127–32.PubMedCrossRef
56.
Hoffman WH, Jueppner HW, DeYoung BR, O'Dorisio MS, Given KS. Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome. American Journal of Medical Genetics Part A. 2005;134A:233–6.CrossRef
57.
Tieder M, Modai D, Samuel R, Arie R, Halabe A, Bab I, et al. Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med. 1985;312:611–7.PubMedCrossRef
58.
Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet. 2006;78:179–92.PubMedCrossRef
59.
Lorenz-Depiereux B, Benet-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, et al. Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet. 2006;78:193–201.PubMedCrossRef
60.
Ichikawa S, Sorenson AH, Imel EA, Friedman NE, Gertner JM, Econs MJ. Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab. 2006;91:4022–7.PubMedCrossRef
61.
Phulwani P, Bergwitz C, Jaureguiberry G, Rasoulpour M, Estrada E. Hereditary hypophosphatemic rickets with hypercalciuria and nephrolithiasis-identification of a novel SLC34A3/NaPi-IIc mutation. Am J Med Genet A. 2011;155A(3):626–33.PubMed
Metadaten
Titel
Rickets
verfasst von
M. Zulf Mughal
Publikationsdatum
01.12.2011
Verlag
Current Science Inc.
Erschienen in
Current Osteoporosis Reports / Ausgabe 4/2011
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-011-0081-0

Weitere Artikel der Ausgabe 4/2011

Current Osteoporosis Reports 4/2011 Zur Ausgabe

Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Bone Development in the Fetus and Neonate: Role of the Calciotropic Hormones

Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Quantitative Computed Tomography and Computed Tomography in Children

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Nutrition, Bone, and Aging: An Integrative Physiology Approach

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Anti-Cancer Actions of Denosumab

Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Bone Development: Overview of Bone Cells and Signaling

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Rodent Models of Aging Bone: An Update

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise